Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2

J Neurochem. 2004 Oct;91(2):501-12. doi: 10.1111/j.1471-4159.2004.02749.x.

Abstract

G-protein-coupled receptors signal through Rho to induce actin cytoskeletal rearrangement. We previously demonstrated that thrombin stimulates Rho-dependent process retraction and rounding of 1321N1 astrocytoma cells. Surprisingly, while lysophosphatidic acid (LPA) activated RhoA in 1321N1 cells, it failed to produce cell rounding. Thrombin, unlike LPA, decreased Rac1 activity, and activated (GTPase-deficient) Rac1 inhibited thrombin-stimulated cell rounding, while expression of dominant-negative Rac1 promoted LPA-induced rounding. LPA and thrombin receptors appear to differ in coupling to Gi, as LPA but not thrombin-stimulated 1321N1 cell proliferation was pertussis toxin-sensitive. Blocking Gi with pertussis toxin enabled LPA to induce cell rounding and to decrease activated Rac1. These data support the hypothesis that Rac1 and Gi activation antagonize cell rounding. Thrombin and LPA receptors also differentially activated Gq pathways as thrombin but not LPA increased InsP3 formation and reduced phosphatidylinositol 4,5-bisphosphate (PIP2) levels. Microinjection of the plekstrin homology domain of phospholipase C (PLC)delta1, which binds PIP2, enabled LPA to elicit cell rounding, consistent with a requirement for PIP2 reduction. We suggest that Rho-mediated cytoskeletal responses are enhanced by concomitant reductions in cellular levels of PIP2 and Rac1 activation and thus effected only by G-protein-coupled receptors with appropriate subsets of G protein activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Astrocytoma / drug therapy
  • Astrocytoma / metabolism*
  • Cell Line, Tumor
  • Cell Size / drug effects
  • Cell Size / physiology
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism*
  • DNA / biosynthesis
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism
  • GTP-Binding Protein alpha Subunits, Gq-G11 / metabolism
  • Humans
  • Lysophospholipids / pharmacology*
  • Microinjections
  • Phosphatidylinositol 4,5-Diphosphate / biosynthesis
  • Phosphatidylinositol 4,5-Diphosphate / genetics
  • Phosphatidylinositol 4,5-Diphosphate / physiology*
  • Protein Structure, Tertiary / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Thrombin / pharmacology
  • Type C Phospholipases / drug effects
  • Type C Phospholipases / metabolism
  • rac1 GTP-Binding Protein / drug effects
  • rac1 GTP-Binding Protein / genetics
  • rac1 GTP-Binding Protein / physiology*
  • rho GTP-Binding Proteins / drug effects
  • rho GTP-Binding Proteins / metabolism*

Substances

  • Lysophospholipids
  • Phosphatidylinositol 4,5-Diphosphate
  • DNA
  • Type C Phospholipases
  • Thrombin
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • rac1 GTP-Binding Protein
  • rho GTP-Binding Proteins
  • lysophosphatidic acid